Hemispherx BioPharma, Inc. (NYSEMKT:HEB)
CAPS Rating:
A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
RSS Headlines
Fool UK
Recs
Hemispheryx puts me in mind of a novel called Perfume, by Patrick Susskind. The protagonist is a murderer who lies dormant for years, likened to a tick on a branch, simply awaiting the passage of a warm-blooded animal to latch on and begin sucking its blood.
Hemispheryx the tick left its last host in December, when the FDA finally rejected the Ampligen NDA, and has laid dormant throughout 2010. I believe that soon the tick will sense another blood meal. If not at 0.5, then at 0.4 or maybe 0.3. Don't let your blood get sucked by this tick ...
By the sound of your comments, you should have a thumbs down on this pick rather than a thumbs up. I'm confused.
Read again, carefully.
I have always been impressed by your knowledge of bio stocks. I'm currently long HEB from .45 (just a small position and I already sold half at .55)
But in reading your comment, when I see 0.5, 0.4, 0.3 and then saying don't get sucked by this tick... I start thinking your bearish the stock.
I would actually love to chat with you sometime about bio stocks as my wife is a physician.
He's liking it to a tick, saying it will become bigger and go higher. The stock sucks (like a tick,) but will become engorged (I like imagining with the blood of pumpers and their sheep.) Eventually, though, this tick will become so bloated that it will pop. ;-)
There you go. That wasn't so hard.